β-(piperidino)-p-chloropropiophenone hydrochloride | 5250-05-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: β-(piperidino)-p-chloropropiophenone hydrochloride
• 英文别名: 1-(4-chlorophenyl)-3-(piperidin-1-yl)propane-1-one hydrochloride；1-(4-chlorophenyl)-3-(1-piperidinyl)-1-propanone hydrochloride；1-(4-chloro-phenyl)-3-piperidino-propan-1-one; hydrochloride；1-(4-Chlor-phenyl)-3-piperidino-propan-1-on; Hydrochlorid；1-(4-chlorophenyl)-3-(piperidin-1-yl)-propan-1-one hydrochloride；1-(4-Chlorophenyl)-3-piperidin-1-ium-1-ylpropan-1-one;chloride
• CAS: 5250-05-5
• 化学式: C₁₄H₁₈ClNO*ClH
• 分子量: 288.217
• InChiKey: QIHSXEWCSJYSTH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.82
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  20.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  β-(piperidino)-p-chloropropiophenone hydrochloride 在 正丁基锂 作用下， 以 四氢呋喃 为溶剂， 反应 49.0h， 生成 3-(4-chlorophenyl)-3-[2-(piperidin-1-yl)-ethyl]-isochroman-1-one hydrochloride
  参考文献：
  名称：

  Isochromanone-based urotensin-II receptor agonists

  摘要：

  A series of analogues of the selective non-peptide urotensin II (UII) receptor agonist 3-(4-chlorophenyl)-3-(2-dimethylaminoethyl)-isochroman- 1-one (AC-7954, 1) was synthesized and evaluated for UII agonist activity using a functional cell-based assay. The introduction of a methyl group in the 4-position resulted in a complete loss of activity, whereas substituents in the aromatic rings were beneficial. Sterically demanding amino groups were also detrimental to the activity. Several potent agonists were identified, six compounds being equally or more potent than 1. The most potent compound in the series was the 6,7-dimethyl analogue of 1 (16, pEC(50) 6.87). The racemate of 16 was resolved into the pure enantiomers using preparative straight phase HPLC. It was shown that the potency resides in the (+)-enantiomer (pEC(50) 7.11). The synthesized compounds seem to be selective for the UII receptor as no activities were observed at the closely related SSTR3 and 5 receptors. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.01.056
• 作为产物：
  描述：

  哌啶 、 3,4'-二氯苯丙酮 在 盐酸 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 12.0h， 以80%的产率得到β-(piperidino)-p-chloropropiophenone hydrochloride
  参考文献：
  名称：

  [EN] UROTENSIN II RECEPTOR MODULATORS
  [FR] MODULATEURS DU RECEPTEUR DE L'UROTENSINE II

  摘要：

  本文披露了根据本文所定义的与人类尿嘧啶 II 受体形成络合物的 Formula I 化合物，或其盐或前药。还披露了根据本文所定义的 Formula II 化合物，或其盐或前药。还披露了使用 Formula I 化合物、Formula II 化合物、或其盐或前药来调节尿嘧啶 II 受体活性的方法。此外，还披露了治疗与尿嘧啶 II 受体活性相关疾病的方法。

  公开号：

  WO2003104216A1

文献信息

• Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes
  作者：Kaan Kucukoglu、Halise Inci Gul、Parham Taslimi、Ilhami Gulcin、Claudiu T. Supuran

  DOI：10.1016/j.bioorg.2019.02.008

  日期：2019.5

  their inhibitory activity against hCA I, hCA II, and AChE enzymes. All compounds in N, P, and R-series inhibited hCAs (I and II) and AChE more efficiently than the reference compounds acetazolamide (AZA), and tacrine. According to the activity results, the most effective inhibitory compounds were in R-series with the Ki values of 203 ± 55-473 ± 67 nM and 200 ± 34-419 ± 94 nM on hCA I, and hCA II, respectively

  最近，抑制碳酸酐酶（hCA）和乙酰胆碱酯酶（AChE）作为药物干预多种疾病（如青光眼，癫痫，肥胖，癌症和阿尔茨海默氏病）的一种有希望的方法。牢记这一点，合成了N，N'-双[（（1-芳基-3-杂芳基）亚丙基]肼二盐酸盐N1-N11，P1，P4-P8和R1-R6，以研究其对hCA的抑制活性I，hCA II和AChE酶。N，P和R系列中的所有化合物均比参考化合物乙酰唑胺（AZA）和他克林更有效地抑制hCA（I和II）和AChE。根据活性结果，对hCA I和hCA II而言，最有效的抑制化合物为R系列，Ki值分别为203±55-473±67 nM和200±34-419±94 nM。N，N' -N系列中的双[1-（4-氟苯基）-3-（吗啉-4-基）亚丙基]肼二盐酸盐N8，N，N'-双[1-（4-羟基苯基）-3-（ P系列的哌啶-1-基）亚丙基]肼二盐酸盐和N，N'-双[1-（4-氯苯基）-3-（吡咯烷-1-基]亚丙基]肼二盐酸盐R5，
• Synthesis of Mannich Bases by Two Different Methods and Evaluation of their Acetylcholine Esterase and Carbonic Anhydrase Inhibitory Activities
  作者：Halise I. Gul、Alkan Demirtas、Gokbay Ucar、Parham Taslimi、|lhami Gulcin

  DOI：10.2174/1570180814666161128120612

  日期：2017.4.6

  biological activities including carbonic anhydrase (CA) inhibitory and acetylcholine esterase inhibitory (AChE) activities. Objective: It was aimed to synthesize Mannich bases, 1-aryl-3-(morpholin-4-yl/piperidin-1-yl)-1- propanone hydrochloride, by microwave irradiation and conventional heating methods to compare the methods in terms of reaction times and yields and to investigate their inhibitory effects on

  背景：曼尼希碱是药物化学中的重要化合物。它们具有广泛的生物学活性，包括碳酸酐酶（CA）抑制和乙酰胆碱酯酶抑制（AChE）活性。 目的：采用微波辐射法和常规加热法合成曼尼希碱1-芳基-3-（吗啉-4-基/哌啶-1-基）-1-丙烷盐酸盐，比较反应方法。次数和产量，并研究其对AChE酶和CA同工酶的抑制作用。 方法：使用常规加热和微波辐射方法在不同反应条件下合成曼尼希碱。根据文献方法评估化合物对CA同工酶和AChE的抑制作用。 结果：针对hCA I，II和AChE评估了化合物的IC50和Ki值。与所用参考文献相比，该化合物具有更有效或相等的Ki值。 结论：这项研究对曼尼希基础库的综合策略做出了重要贡献。根据IC50或Ki值，A系列中的化合物6与吗啉和B系列中的15与哌啶对hCA I和/或II同工酶以及A系列中的化合物4和11、13、14、15、16和针对AChE的B系列研究中的18似乎是该研究的主要化合物。
• Synthesis and bioactivity studies of 1-aryl-3-(2-hydroxyethylthio)-1-propanones
  作者：Elif Unluer、Halise Inci Gul、Alkan Demirtas、Hiroshi Sakagami、Naoki Umemura、Muhammet Tanc、Cavit Kazaz、Claudiu T. Supuran

  DOI：10.1080/14756366.2016.1209495

  日期：2016.11.3

  A series of Mannich bases having piperidine moiety were reacted with 2-mercaptoethanol, leading to 1-aryl-3-piperidine-4-yl-1-propanone hydrochlorides. The cytotoxicity and carbonic anhydrase inhibitory activities of these new compounds were evaluated. Among the compounds, only one derivative, nitro substituent bearing EU9, showed an effective cytotoxicity, although weak tumor specificity against human

  使具有哌啶部分的一系列曼尼希碱与2-巯基乙醇反应，得到1-芳基-3-哌啶-4-基-1-丙烷丙酮盐酸盐。评价了这些新化合物的细胞毒性和碳酸酐酶抑制活性。在这些化合物中，只有一种衍生物，即带有EU9的硝基取代基，显示出有效的细胞毒性，尽管针对人口腔恶性细胞和非恶性细胞的肿瘤特异性较弱。该化合物诱导HSC-2口腔鳞状细胞癌细胞凋亡，但不会诱导人牙龈成纤维细胞凋亡。因此，有必要对该铅进行化学修饰，以进一步研究其作为候选药物的作用，并获得具有更好活性曲线的化合物。
• Synthesis of new N,N′-bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides and evaluation of their cytotoxicity against human hepatoma and breast cancer cells
  作者：Kaan Kucukoglu、H. Inci Gul、Rengul Cetin-Atalay、Yosra Baratli、Anne-Laure Charles、Murat Sukuroglu、Mustafa Gul、Bernard Geny

  DOI：10.3109/14756366.2013.795562

  日期：2014.6.1

  N,N'-Bis[1-aryl-3-(piperidine-1-yl)propylidene] hydrazine dihydrochlorides were synthesized by the reaction of 2 mols of 1-aryl-3-(piperidine-1-yl)-1-propanone hydrochlorides with 1 mol of hydrazine hydrate. Aryl part was C6H5 (P1), 4-CH3C6H4 (P2), 4-CH3OC6H4 (P3), 4-HOC6H4 (P4), 4-ClC6H4 (P5), 3-CH3OC6H4 (P6), 4-FC6H4 (P7) and 4-BrC6H4 (P8). Except P1, all compounds were reported for the first time. The chemical structures were confirmed by UV, H-1 NMR, C-13 NMR and HRMS spectra. P1, P2, P7 and P8 against human hepatoma (Huh7) cells and P1, P2, P4, P5, P6, P7 and P8 against breast cancer (T47D) cells have shown cytotoxicity. P1, P2 and P7 had more potent cytotoxicity against Huh7 cells than the reference compound 5-FU, whereas only P2 was more potent than the 5-FU against T47D cells. Representative compound P7 inhibited the mitochondrial respiration at 144, 264 and 424 mu M concentrations dose-dependantly in liver homogenates. The results suggest that P1, P2, P7 and P8 may serve as model compounds for further synthetic studies.
• Pandeya; Sowmyalakshmi; Panda, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2003, vol. 42, # 10, p. 2657 - 2661
  作者：Pandeya、Sowmyalakshmi、Panda、Pandeya、Stables

  DOI：——

  日期：——